publication . Article . 2017

Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer

K. M. Nyushko; T. V. Ustinova; A. A. Paychadze; B. Ya. Alekseev; A. A. Krasheninnikov; G. S. Gevorgyan; L. V. Bolotina; A. S. Kalpinskiy; N. V. Vorob’ev; A. D. Kaprin;
Open Access Russian
  • Published: 01 Oct 2017 Journal: Onkourologiâ (issn: 1726-9776, eissn: 1996-1812, Copyright policy)
  • Publisher: ABV-press
Abstract
Prostate cancer (PC) is now one of the most common malignancies among men. Radical prostatectomy is the most commonly used therapy option for patients with localized PC. The appropriateness of surgical treatment for locally advanced and lymphogenic metastatic PC remains controversial, as the probability of non-radical intervention increases significantly and the risk for disease progression becomes higher. At the same time, interest in surgical treatment in patients with PC at high risk of progression, including those with lymphogenic metastases has recently increased greatly. There are more and more studies demonstrating improved survival rates in patients with...
Subjects
free text keywords: neoadjuvant chemohormonal therapy, surgical treatment for metastatic prostate cancer, combined chemohormonal therapy, docetaxel, novotax, Medicine, R, business.industry, business, Oncology, medicine.medical_specialty, Internal medicine, Prostate cancer, medicine.disease, Prostatectomy, medicine.medical_treatment
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2017

Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer

K. M. Nyushko; T. V. Ustinova; A. A. Paychadze; B. Ya. Alekseev; A. A. Krasheninnikov; G. S. Gevorgyan; L. V. Bolotina; A. S. Kalpinskiy; N. V. Vorob’ev; A. D. Kaprin;